GZI Real Estate Investment Trust (a Hong Kong collective investment scheme authorised under section 104of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong))(Stock Code: 405) Managed by GZI REIT Asset Management Limited NOTICE OF ANNUAL GENERAL MEETING NOTICE IS HEREBY GIVEN that an Annual General Meeting of unitholders of GZI Real Estate
Investment Trust (“GZI REIT”) will be held at Falcon Room, Lower Ground, Luk Kwok Hotel, 72
Gloucester Road, Wanchai, Hong Kong on Tuesday, 15 May 2007 at 10:00 a.m. for the following
(1) To note the audited financial statements of GZI REIT together with the Auditors’ Report for
(2) To note the appointment of Auditors of GZI REIT and the fixing of their remuneration. GZI REIT Asset Management Limited as manager of GZI Real Estate Investment Trust Yu Tat Fung
(a) The Register of Unitholders of GZI REIT will be closed from Tuesday, 8 May 2007 to
Tuesday, 15 May 2007, both days inclusive, during which period no transfer of units will be
effected. In order to qualify for attending the Annual General Meeting, all unit certificates
with completed transfer forms must be lodged with GZI REIT’s Unit Registrar, Tricor
Investor Services Limited at 26/F Tesbury Centre, 28 Queen’s Road East, Wanchai, Hong
Kong, not later than 4:00 p.m. on Monday, 7 May 2007.
(b) Any unitholder entitled to attend the Annual General Meeting is entitled to appoint a proxy
(c) In order to be valid, an instrument of proxy, together with any power of attorney or other
authority, if any, under which it is signed or a notarially certified copy of such power of
attorney or authority, if any, must be deposited at GZI REIT’s Unit Registrar, Tricor Investor
Services Limited at 26/F Tesbury Centre, 28 Queen’s Road East, Wanchai, Hong Kong not
later than 48 hours before the commencement of the Annual General Meeting. The directors of GZI REIT Asset Management Limited as at the date of this notice are Mr. LiangNingguang (Chairman and Executive Director), Mr. Liu Yongjie as Executive Director; Mr. LiangYoupan as Non-executive Director and Messrs. Chan Chi On, Derek, Lee Kwan Hung, Eddieand Chan Chi Fai, Brian as Independent Non-executive Directors.GZI Real Estate Investment Trust (a Hong Kong collective investment scheme authorised under section 104of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong))(Stock Code: 405) Managed by GZI REIT Asset Management Limited PROXY FORM FOR USE BY UNITHOLDERS AT THE ANNUAL GENERAL MEETING
being a registered holder of (note 2)
Trust (“GZI REIT”) hereby appoint (note 3)
as my/our proxy to attend and act on my/our behalf at the Annual General Meeting of unitholdersof GZI REIT to be held at Falcon Room, Lower Ground, Luk Kwok Hotel, 72 Gloucester Road,Wanchai, Hong Kong on Tuesday, 15 May 2007 at 10:00 a.m. and at any adjournment thereof.
Full name(s) and address(es) to be inserted in BLOCK CAPITALS.
Please insert the number of units registered in your name(s). If no number is inserted, this proxy form will bedeemed to relate to all the units in GZI REIT registered in your name(s).
Any unitholder entitled to attend the Annual General Meeting is entitled to appoint a proxy to attend in his stead.
This proxy form must be signed by the appointor or his attorney duly authorised in writing or, in the case of acorporation, must be either under its common seal or under hand of an officer, attorney or other person dulyauthorised.
In order to be valid, this proxy form, together with any power of attorney or other authority, if any, under which itis signed or a notarially certified copy of such power of attorney or authority, if any, must be deposited at GZIREIT’s Unit Registrar, Tricor Investor Services Limited at 26/F Tesbury Centre, 28 Queen’s Road East, Wanchai,Hong Kong not later than 48 hours before the commencement of the Annual General Meeting. ANY ALTERATION MADE TO THIS PROXY FORM MUST BE INITIALLED BY THE UNITHOLDER WHO SIGNS IT.
Osteoporos IntDOI 10.1007/s00198-008-0573-7Additive benefit of higher testosterone levels and vitamin Dplus calcium supplementation in regard to fall riskreduction among older men and womenH. A. Bischoff-Ferrari & E. J. Orav & B. Dawson-HughesReceived: 28 September 2007 / Accepted: 3 December 2007 # International Osteoporosis Foundation and National Osteoporosis Foundation 2008uals a
FORMAS FARMACÊUTICAS: Xarope 0,4 mg/mL APRESENTAÇÕES: Embalagem com 1e 50 frascos de 120 mL + copo medida USO PEDIÁTRICO E ADULTO COMPOSIÇÃO: Cada ml contém: sulfato de salbutamol . 0,484 mg (equivalente a 0,4 mg de salbutamol) veículo q.s.p. . 1,0 mL (Veículo: sacarose, sacarina sódica, ciclamato de sódio, ácido cítrico, citrato de sódio, metilparabeno, propilparabeno,